The Clinical and Prognostic Features of PRES
NCT05143710 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 354
Last updated 2022-03-02
Summary
The purpose of this study is to determine the features of clinical imaging, disease severity and pregnancy outcomes in posterior reversible encephalopathy syndrome with preeclampsia or eclampsia.
Conditions
- Posterior Reversible Encephalopathy Syndrome
- Pregnancy Outcomes
- Preeclampsia
- Eclampsia
Interventions
- DIAGNOSTIC_TEST
-
PRES in PE or E
patients diagnosed with posterior reversible encephalopathy syndrome with preeclampsia or eclampsia
Sponsors & Collaborators
-
Dunjin Chen
lead OTHER
Eligibility
- Min Age
- 16 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-10-01
- Primary Completion
- 2022-01-31
- Completion
- 2022-01-31
Countries
- China
Study Locations
More Related Trials
-
Prediction of Early Pre-eclampsia From Maternal Factors, Biophysical and Biochemical Markers at First Trimester
NCT02990767 ·Status: UNKNOWN
-
Improved Characterisation of Eclampsia
NCT05199558 ·Status: UNKNOWN
-
Clinical Characteristics and Prognosis of Acute Stroke in Pregnancy and Puerperium
NCT06527807 ·Status: RECRUITING
-
Chronic Remote Ischemic Preconditioning as a Complement to Conventional Prenatal Care for Preeclampsia
NCT05564988 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Project of Gestational Hypertension and Preeclampsia Screening and Prevention Center
NCT06383858 ·Status: RECRUITING
-
Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care
NCT05056701 ·Status: RECRUITING ·Phase: NA
-
Point-of-care Ultrasound Abnormalities in Early Onset Preeclampsia
NCT05662995 ·Status: UNKNOWN ·Phase: NA
-
The Association Between Different Markers With Development of Maternal and Neonatal Complications in Women With Severe Preeclampsia
NCT07125599 ·Status: COMPLETED
-
Cardiovascular Risk After Preeclampsia
NCT05277233 ·Status: RECRUITING
-
Prediction of Adverse Perinatal Outcome for Preeclampsia in Sichuan Province of China
NCT01804751 ·Status: UNKNOWN
-
Prediction of Preeclampsia (PE) at 11-13 Week
NCT03554681 ·Status: COMPLETED
-
Novel Biomarkers of Preeclampsia, Aquaporin, Fatty Acid, and S110B
NCT03567551 ·Status: COMPLETED
-
The Investigation of the Prediction Model and Prevention Strategy of Serious Pregnancy Complications in Hypertensive Disorders of Pregnancy Based on the Chinese Population
NCT05089175 ·Status: UNKNOWN
-
Evaluation of Cardiovascular Risk After Preeclampsia in General Practitioners and Patients
NCT06059937 ·Status: COMPLETED
-
Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy
NCT04075708 ·Status: COMPLETED
-
Factors Predicting Transformation of Non Severe Pre-eclampsia Into Pre-eclampsia With Severe Features
NCT05152550 ·Status: UNKNOWN
-
Serpin C and Soluble Fms-like Tyrosine Kinase-1 Levels in Normotensive Pregnant Women May Predict the Development of Preeclampsia
NCT06214702 ·Status: COMPLETED
-
Pregnancy Outcomes in Normotensive VS stage1 Hypertension: a Prospective Observational Study
NCT06339749 ·Status: RECRUITING
-
Risk Prediction Models for Adverse Maternal and Neonatal Outcomes in Preeclampsia
NCT04058405 ·Status: COMPLETED
-
Early Prediction and Randomised Prevention of Preeclampsia With Low Dose Aspirin in Chinese Cohort
NCT04631627 ·Status: UNKNOWN ·Phase: PHASE4
-
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
NCT03767803 ·Status: UNKNOWN
-
A Clinical Study of Fundus Findings in Toxaemia of Pregnancy
NCT03076619 ·Status: COMPLETED
-
Evaluation of Fetoplacental Oxygenation With Functional MRI in Pregnant Women
NCT02238301 ·Status: COMPLETED ·Phase: NA
-
Placental Growth Factor Assessment of Women With Suspected Pre-eclampsia
NCT02881073 ·Status: COMPLETED ·Phase: NA
-
Pregnant Women With Pulmonary Hypertension in China
NCT05198206 ·Status: UNKNOWN